Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 5/2017

01-09-2017 | Original Article

Risk factors for poor bone health in primary mitochondrial disease

Authors: Shifa S. Gandhi, Colleen Muraresku, Elizabeth M. McCormick, Marni J. Falk, Shana E. McCormack

Published in: Journal of Inherited Metabolic Disease | Issue 5/2017

Login to get access

Abstract

Introduction

Primary mitochondrial disease is caused by either mitochondrial or nuclear DNA mutations that impact the function of the mitochondrial respiratory chain. Individuals with mitochondrial disorders have comorbid conditions that may increase their risk for poor bone health. The objective of this retrospective electronic medical record (EMR) review was to examine risk factors for poor bone health in children and adults with primary mitochondrial disease.

Methods

Eighty individuals with confirmed clinical and genetic diagnoses of primary mitochondrial disease at the Children’s Hospital of Philadelphia (CHOP) were included in this study. Risk factors and bone health outcomes were collected systematically, including: anthropometrics (low BMI), risk-conferring co-morbidities and medications, vitamin D status, nutrition, immobility, fracture history, and, where available, dual energy x-ray absorptiometry (DXA) bone mineral density (BMD) results.

Results

Of patients 73% (n = 58) had at least one risk factor and 30% (n = 24) had four or more risk factors for poor bone health. The median number of risk factors per participant was 2, with an interquartile interval (IQI 0–4). In the subset of the cohort who were known to have sustained any lifetime fracture (n = 11), a total of 16 fractures were reported, six of which were fragility fractures, indicative of a clinically significant decrease in bone strength.

Conclusions

The prevalence of risk factors for poor bone health in primary mitochondrial disease is high. As part of supportive care, practitioners should address modifiable risk factors to optimize bone health, and have a low threshold to evaluate clinical symptoms that could suggest occult fragility fracture.
Appendix
Available only for authorised users
Literature
go back to reference Barry DW, Kohrt WM (2008) Exercise and the preservation of bone health. J Cardiopulm Rehabil Prev 28(3):153–162CrossRefPubMed Barry DW, Kohrt WM (2008) Exercise and the preservation of bone health. J Cardiopulm Rehabil Prev 28(3):153–162CrossRefPubMed
go back to reference Bishop N et al (2014) Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 pediatric official positions. J Clin Densitom 17(2):275–280CrossRefPubMed Bishop N et al (2014) Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 pediatric official positions. J Clin Densitom 17(2):275–280CrossRefPubMed
go back to reference Chinnery PF (1993) Mitochondrial disorders overview. In: Pagon RA et al (ed) GeneReviews(R). University of Washington, Seattle Chinnery PF (1993) Mitochondrial disorders overview. In: Pagon RA et al (ed) GeneReviews(R). University of Washington, Seattle
go back to reference Cholley F et al (2001) Mitochondrial respiratory chain deficiency revealed by hypothermia. Neuropediatrics 32(2):104–106CrossRefPubMed Cholley F et al (2001) Mitochondrial respiratory chain deficiency revealed by hypothermia. Neuropediatrics 32(2):104–106CrossRefPubMed
go back to reference De Block CE et al (2004) A novel 7301-bp deletion in mitochondrial DNA in a patient with Kearns-Sayre syndrome, diabetes mellitus, and primary amenorrhoea. Exp Clin Endocrinol Diabetes 112(2):80–83CrossRefPubMed De Block CE et al (2004) A novel 7301-bp deletion in mitochondrial DNA in a patient with Kearns-Sayre syndrome, diabetes mellitus, and primary amenorrhoea. Exp Clin Endocrinol Diabetes 112(2):80–83CrossRefPubMed
go back to reference Dobson PF et al (2016) Unique quadruple immunofluorescence assay demonstrates mitochondrial respiratory chain dysfunction in osteoblasts of aged and PolgA(−/−) mice. Sci Rep 6:31907CrossRefPubMedPubMedCentral Dobson PF et al (2016) Unique quadruple immunofluorescence assay demonstrates mitochondrial respiratory chain dysfunction in osteoblasts of aged and PolgA(−/−) mice. Sci Rep 6:31907CrossRefPubMedPubMedCentral
go back to reference Dosa NP et al (2007) Incidence, prevalence, and characteristics of fractures in children, adolescents, and adults with spina bifida. J Spinal Cord Med 30(Suppl 1):S5–S9CrossRefPubMedPubMedCentral Dosa NP et al (2007) Incidence, prevalence, and characteristics of fractures in children, adolescents, and adults with spina bifida. J Spinal Cord Med 30(Suppl 1):S5–S9CrossRefPubMedPubMedCentral
go back to reference Drezner MK (2004) Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav 5(Suppl 2):S41–S47CrossRefPubMed Drezner MK (2004) Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav 5(Suppl 2):S41–S47CrossRefPubMed
go back to reference Fedorenko M, Wagner ML, Wu BY (2015) Survey of risk factors for osteoporosis and osteoprotective behaviors among patients with epilepsy. Epilepsy Behav 45:217–222CrossRefPubMed Fedorenko M, Wagner ML, Wu BY (2015) Survey of risk factors for osteoporosis and osteoprotective behaviors among patients with epilepsy. Epilepsy Behav 45:217–222CrossRefPubMed
go back to reference Gordon CM et al (2014) 2013 pediatric position development conference: executive summary and reflections. J Clin Densitom 17(2):219–224CrossRefPubMed Gordon CM et al (2014) 2013 pediatric position development conference: executive summary and reflections. J Clin Densitom 17(2):219–224CrossRefPubMed
go back to reference Grieff M, Bushinsky DA (2011) Diuretics and disorders of calcium homeostasis. Semin Nephrol 31(6):535–541CrossRefPubMed Grieff M, Bushinsky DA (2011) Diuretics and disorders of calcium homeostasis. Semin Nephrol 31(6):535–541CrossRefPubMed
go back to reference Harvey JN, Barnett D (1992) Endocrine dysfunction in Kearns-Sayre syndrome. Clin Endocrinol 37(1):97–103CrossRef Harvey JN, Barnett D (1992) Endocrine dysfunction in Kearns-Sayre syndrome. Clin Endocrinol 37(1):97–103CrossRef
go back to reference Holick MF et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930CrossRefPubMed Holick MF et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930CrossRefPubMed
go back to reference Kalkwarf HJ et al (2007) The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab 92(6):2087–2099CrossRefPubMed Kalkwarf HJ et al (2007) The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab 92(6):2087–2099CrossRefPubMed
go back to reference Kuczmarski RJ et al (2000) CDC growth charts: United States. Adv Data 314:1–27 Kuczmarski RJ et al (2000) CDC growth charts: United States. Adv Data 314:1–27
go back to reference Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL (2002) 2000 CDC Growth Charts for the United States: methods and development. Vital and Health Statistics Series 11, Data from the National Health Survey (246):1–190 Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL (2002) 2000 CDC Growth Charts for the United States: methods and development. Vital and Health Statistics Series 11, Data from the National Health Survey (246):1–190
go back to reference Lewiecki EM et al (2016) Best practices for dual-energy X-ray absorptiometry measurement and reporting: International Society for Clinical Densitometry Guidance. J Clin Densitom 19(2):127–140CrossRefPubMed Lewiecki EM et al (2016) Best practices for dual-energy X-ray absorptiometry measurement and reporting: International Society for Clinical Densitometry Guidance. J Clin Densitom 19(2):127–140CrossRefPubMed
go back to reference Lindsey RC, Mohan S (2016) Skeletal effects of growth hormone and insulin-like growth factor-I therapy. Mol Cell Endocrinol 432:44–55CrossRefPubMed Lindsey RC, Mohan S (2016) Skeletal effects of growth hormone and insulin-like growth factor-I therapy. Mol Cell Endocrinol 432:44–55CrossRefPubMed
go back to reference Mazziotti G et al (2016) Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines. Endocrine doi:10.1007/s12020-016-1146-8 Mazziotti G et al (2016) Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines. Endocrine doi:10.1007/s12020-016-1146-8
go back to reference McDonald DG et al (2002) Fracture prevalence in Duchenne muscular dystrophy. Dev Med Child Neurol 44(10):695–698CrossRefPubMed McDonald DG et al (2002) Fracture prevalence in Duchenne muscular dystrophy. Dev Med Child Neurol 44(10):695–698CrossRefPubMed
go back to reference Misra M et al (2008) Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 122(2):398–417CrossRefPubMed Misra M et al (2008) Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 122(2):398–417CrossRefPubMed
go back to reference Murphy JL et al (2008) Resistance training in patients with single, large-scale deletions of mitochondrial DNA. Brain 131(Pt 11):2832–2840CrossRefPubMed Murphy JL et al (2008) Resistance training in patients with single, large-scale deletions of mitochondrial DNA. Brain 131(Pt 11):2832–2840CrossRefPubMed
go back to reference Parikh S et al (2015) Diagnosis and management of mitochondrial disease: a consensus statement from the mitochondrial Medicine Society. Genet Med 17(9):689–701CrossRefPubMed Parikh S et al (2015) Diagnosis and management of mitochondrial disease: a consensus statement from the mitochondrial Medicine Society. Genet Med 17(9):689–701CrossRefPubMed
go back to reference Pavlovic A et al (2013) Relationship of thoracic kyphosis and lumbar lordosis to bone mineral density in women. Osteoporos Int 24(8):2269–2273CrossRefPubMed Pavlovic A et al (2013) Relationship of thoracic kyphosis and lumbar lordosis to bone mineral density in women. Osteoporos Int 24(8):2269–2273CrossRefPubMed
go back to reference Shiek Ahmad B et al (2016) Bone mineral changes in epilepsy patients during initial years of antiepileptic drug therapy. J Clin Densitom doi:10.1016/j.jocd.2016.07.008. Shiek Ahmad B et al (2016) Bone mineral changes in epilepsy patients during initial years of antiepileptic drug therapy. J Clin Densitom doi:10.1016/j.jocd.2016.07.008.
go back to reference Sinha A et al (2013) Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J Clin Endocrinol Metab 98(3):E509–E513CrossRefPubMed Sinha A et al (2013) Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J Clin Endocrinol Metab 98(3):E509–E513CrossRefPubMed
go back to reference Stacpoole PW et al (2012) Design and implementation of the first randomized controlled trial of coenzyme CoQ(1)(0) in children with primary mitochondrial diseases. Mitochondrion 12(6):623–629CrossRefPubMedPubMedCentral Stacpoole PW et al (2012) Design and implementation of the first randomized controlled trial of coenzyme CoQ(1)(0) in children with primary mitochondrial diseases. Mitochondrion 12(6):623–629CrossRefPubMedPubMedCentral
go back to reference Toth M, Grossman A (2013) Glucocorticoid-induced osteoporosis: lessons from Cushing’s syndrome. Clin Endocrinol 79(1):1–11CrossRef Toth M, Grossman A (2013) Glucocorticoid-induced osteoporosis: lessons from Cushing’s syndrome. Clin Endocrinol 79(1):1–11CrossRef
go back to reference Trifunovic A et al (2004) Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429(6990):417–423CrossRefPubMed Trifunovic A et al (2004) Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429(6990):417–423CrossRefPubMed
go back to reference Tzoufi M et al (2013) A rare case report of simultaneous presentation of myopathy, Addison’s disease, primary hypoparathyroidism, and Fanconi syndrome in a child diagnosed with Kearns-Sayre syndrome. Eur J Pediatr 172(4):557–561CrossRefPubMed Tzoufi M et al (2013) A rare case report of simultaneous presentation of myopathy, Addison’s disease, primary hypoparathyroidism, and Fanconi syndrome in a child diagnosed with Kearns-Sayre syndrome. Eur J Pediatr 172(4):557–561CrossRefPubMed
go back to reference Varanasi SS et al (1999) Mitochondrial DNA deletion associated oxidative stress and severe male osteoporosis. Osteoporos Int 10(2):143–149CrossRefPubMed Varanasi SS et al (1999) Mitochondrial DNA deletion associated oxidative stress and severe male osteoporosis. Osteoporos Int 10(2):143–149CrossRefPubMed
go back to reference Weaver CM et al (2016) The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteoporos Int 27(4):1281–1386CrossRefPubMedPubMedCentral Weaver CM et al (2016) The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteoporos Int 27(4):1281–1386CrossRefPubMedPubMedCentral
go back to reference Weber DR et al (2015) Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using the health improvement network (THIN). Diabetes Care 38(10):1913–1920CrossRefPubMedPubMedCentral Weber DR et al (2015) Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using the health improvement network (THIN). Diabetes Care 38(10):1913–1920CrossRefPubMedPubMedCentral
go back to reference Weger M et al (1999) Incomplete renal tubular acidosis in ‘primary’ osteoporosis. Osteoporos Int 10(4):325–329CrossRefPubMed Weger M et al (1999) Incomplete renal tubular acidosis in ‘primary’ osteoporosis. Osteoporos Int 10(4):325–329CrossRefPubMed
go back to reference Whittaker RG et al (2007) Prevalence and progression of diabetes in mitochondrial disease. Diabetologia 50(10):2085–2089CrossRefPubMed Whittaker RG et al (2007) Prevalence and progression of diabetes in mitochondrial disease. Diabetologia 50(10):2085–2089CrossRefPubMed
go back to reference Zemel BS et al (2010) Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 95(3):1265–1273CrossRefPubMedPubMedCentral Zemel BS et al (2010) Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 95(3):1265–1273CrossRefPubMedPubMedCentral
go back to reference Zemel BS et al (2011) Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab 96(10):3160–3169CrossRefPubMedPubMedCentral Zemel BS et al (2011) Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab 96(10):3160–3169CrossRefPubMedPubMedCentral
Metadata
Title
Risk factors for poor bone health in primary mitochondrial disease
Authors
Shifa S. Gandhi
Colleen Muraresku
Elizabeth M. McCormick
Marni J. Falk
Shana E. McCormack
Publication date
01-09-2017
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 5/2017
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-017-0046-2

Other articles of this Issue 5/2017

Journal of Inherited Metabolic Disease 5/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.